Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $71.7 Billion
- Q1 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 8,341 shares of ARWR stock, worth $209,108. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,341
Previous 8,714
4.28%
Holding current value
$209,108
Previous $266,000
10.53%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ARWR
# of Institutions
296Shares Held
88.5MCall Options Held
905KPut Options Held
387K-
Black Rock Inc. New York, NY15.3MShares$385 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$311 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.56MShares$214 Million2.95% of portfolio
-
State Street Corp Boston, MA6.56MShares$164 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$104 Million2.38% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.65B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...